FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1817643805> ?p ?o ?g. }

• W1817643805 endingPage "16197" @default.
• W1817643805 startingPage "16183" @default.
• W1817643805 abstract "// Mikaella Vouri 1 , Qian An 1 , Matthew Birt 1 , Geoffrey J. Pilkington 1 and Sassan Hafizi 1 1 Institute of Biomedical and Biomolecular Science, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK Correspondence to: Sassan Hafizi, email: // Keywords : Axl receptor tyrosine kinase, small molecule inhibitor, glioma, invasion Received : December 03, 2014 Accepted : April 09, 2015 Published : April 29, 2015 Abstract Glioblastoma multiforme (GBM) often features a combination of tumour suppressor gene inactivation and multiple oncogene overactivation. The Axl receptor tyrosine kinase is found overexpressed in GBM and thought to contribute to invasiveness, chemoresistance and poor survival. Here, we have evaluated the effect of BGB324, a clinical candidate Axl-specific small molecule inhibitor, on the invasive behaviour of human GBM cells in vitro , as an indicator of its potential in GBM therapy and also to elucidate the role of Axl in GBM pathogenesis. Two cultured adult GBM cell lines, SNB-19 and UP007, were treated with Gas6 and/or BGB324, and analysed in assays for survival, 3D colony growth, motility, migration and invasion. Western blot was used to detect protein expression and signal protein phosphorylation. In both cell lines, BGB324 inhibited specifically phosphorylation of Axl as well as Akt kinase further downstream. BGB324 also inhibited survival and proliferation of both cell lines in a concentration-dependent manner, as well as completely suppressing migration and invasion. Furthermore, our results indicate co-operative activation between the Axl and Tyro3 receptors, as well as ligand-independent Axl signalling, to take place in GBM cells. In conclusion, small molecule inhibitor-led targeting of Axl may be a promising therapy for GBM progression." @default.
• W1817643805 created "2016-06-24" @default.
• W1817643805 creator A5003858678 @default.
• W1817643805 creator A5036735525 @default.
• W1817643805 creator A5042207433 @default.
• W1817643805 creator A5053116360 @default.
• W1817643805 creator A5085508022 @default.
• W1817643805 date "2015-04-29" @default.
• W1817643805 modified "2023-09-25" @default.
• W1817643805 title "Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells" @default.
• W1817643805 cites W1482042321 @default.
• W1817643805 cites W1893588436 @default.
• W1817643805 cites W1971609314 @default.
• W1817643805 cites W1983774108 @default.
• W1817643805 cites W1991291732 @default.
• W1817643805 cites W2002041325 @default.
• W1817643805 cites W2007775311 @default.
• W1817643805 cites W2013022837 @default.
• W1817643805 cites W2015023486 @default.
• W1817643805 cites W2016660437 @default.
• W1817643805 cites W2039687515 @default.
• W1817643805 cites W2040685978 @default.
• W1817643805 cites W2051035972 @default.
• W1817643805 cites W2056010443 @default.
• W1817643805 cites W2075091575 @default.
• W1817643805 cites W2081982964 @default.
• W1817643805 cites W2088680545 @default.
• W1817643805 cites W2096287682 @default.
• W1817643805 cites W2099540110 @default.
• W1817643805 cites W2105904346 @default.
• W1817643805 cites W2106382644 @default.
• W1817643805 cites W2113765051 @default.
• W1817643805 cites W2116509746 @default.
• W1817643805 cites W2117716725 @default.
• W1817643805 cites W2118258530 @default.
• W1817643805 cites W2119710439 @default.
• W1817643805 cites W2120702845 @default.
• W1817643805 cites W2122375037 @default.
• W1817643805 cites W2126073113 @default.
• W1817643805 cites W2131681221 @default.
• W1817643805 cites W2131899060 @default.
• W1817643805 cites W2132286757 @default.
• W1817643805 cites W2133902177 @default.
• W1817643805 cites W2148977460 @default.
• W1817643805 cites W2153326117 @default.
• W1817643805 cites W2160382843 @default.
• W1817643805 cites W4242403727 @default.
• W1817643805 doi "https://doi.org/10.18632/oncotarget.3952" @default.
• W1817643805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4599264" @default.
• W1817643805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25980499" @default.
• W1817643805 hasPublicationYear "2015" @default.
• W1817643805 type Work @default.
• W1817643805 sameAs 1817643805 @default.
• W1817643805 citedByCount "44" @default.
• W1817643805 countsByYear W18176438052016 @default.
• W1817643805 countsByYear W18176438052017 @default.
• W1817643805 countsByYear W18176438052018 @default.
• W1817643805 countsByYear W18176438052019 @default.
• W1817643805 countsByYear W18176438052020 @default.
• W1817643805 countsByYear W18176438052021 @default.
• W1817643805 countsByYear W18176438052022 @default.
• W1817643805 crossrefType "journal-article" @default.
• W1817643805 hasAuthorship W1817643805A5003858678 @default.
• W1817643805 hasAuthorship W1817643805A5036735525 @default.
• W1817643805 hasAuthorship W1817643805A5042207433 @default.
• W1817643805 hasAuthorship W1817643805A5053116360 @default.
• W1817643805 hasAuthorship W1817643805A5085508022 @default.
• W1817643805 hasBestOaLocation W18176438051 @default.
• W1817643805 hasConcept C101544691 @default.
• W1817643805 hasConcept C11960822 @default.
• W1817643805 hasConcept C157333092 @default.
• W1817643805 hasConcept C172811965 @default.
• W1817643805 hasConcept C2778227246 @default.
• W1817643805 hasConcept C42362537 @default.
• W1817643805 hasConcept C502942594 @default.
• W1817643805 hasConcept C5364575 @default.
• W1817643805 hasConcept C62478195 @default.
• W1817643805 hasConcept C75217442 @default.
• W1817643805 hasConcept C86803240 @default.
• W1817643805 hasConcept C95444343 @default.
• W1817643805 hasConceptScore W1817643805C101544691 @default.
• W1817643805 hasConceptScore W1817643805C11960822 @default.
• W1817643805 hasConceptScore W1817643805C157333092 @default.
• W1817643805 hasConceptScore W1817643805C172811965 @default.
• W1817643805 hasConceptScore W1817643805C2778227246 @default.
• W1817643805 hasConceptScore W1817643805C42362537 @default.
• W1817643805 hasConceptScore W1817643805C502942594 @default.
• W1817643805 hasConceptScore W1817643805C5364575 @default.
• W1817643805 hasConceptScore W1817643805C62478195 @default.
• W1817643805 hasConceptScore W1817643805C75217442 @default.
• W1817643805 hasConceptScore W1817643805C86803240 @default.
• W1817643805 hasConceptScore W1817643805C95444343 @default.
• W1817643805 hasIssue "18" @default.
• W1817643805 hasLocation W18176438051 @default.
• W1817643805 hasLocation W18176438052 @default.
• W1817643805 hasLocation W18176438053 @default.
• W1817643805 hasLocation W18176438054 @default.
• W1817643805 hasLocation W18176438055 @default.

• next